3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with Convulsions, Grand Mal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapman, AG; Smith, SE | 1 |
| Bardgett, ME; Farah, JM; Taylor, GT | 1 |
2 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and Convulsions, Grand Mal
| Article | Year |
|---|---|
Acute and chronic anticonvulsant effects of D(-)CPPene in genetically epilepsy-prone rats.
Topics: Animals; Anticonvulsants; Behavior, Animal; Epilepsy; Epilepsy, Tonic-Clonic; Female; Male; Piperazines; Postural Balance; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1993 |
Systemic NMDA treatment increases plasma ACTH in the neonatal female and male rat.
Topics: Adrenocorticotropic Hormone; Animals; Animals, Newborn; Epilepsy, Tonic-Clonic; Female; Injections, Subcutaneous; Male; N-Methylaspartate; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate | 1992 |